Transcarent recently announced that it raised $126 million in Series D funding led by General Catalyst and 7wireVentures.

SmarterDx — an AI startup that provides clinical review and quality audits for medical claims — closed a $50 million Series B funding round, bringing its total funding to date to $71 million.

Novo Holdings’ planned acquisition of Catalent is facing another delay. Just weeks after Novo Holdings decided to resubmit ...

A new company emerged out of stealth mode this week at the SynBioBeta conference in San Jose. The startup, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the ...

Takeda Pharmaceutical has secured an option on an Alzheimer’s disease immunotherapy from AC Immune that is on track to report ...

Alpha Sophia, a premier platform for commercial intelligence in healthcare, has launched its new podcast series, Alpha Sophia Spotlight. Aimed at medtech startups and small to medium-sized ...

As the burden of documentation and various other administrative duties has increased, physician burnout has reached historical levels. In response, EHR vendors are embedding generative AI tools to ...

Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various ...

While acknowledging the pivotal role of technology in enhancing health, we are still in the early innings for digital health as it relates to the transformative impact many had expected to come to ...

Enforcers of anti-kickback laws are turning up the heat on hospitals, health systems and physicians alike, with 2024 on track to see ever increasing penalties and stress on providers. Commonly ...

ŌURA, a wearable device company, announced Friday that it has two new heart health features that will become available in late May. One feature is for understanding users’ cardiovascular age ...

Clinical trials today require more patient involvement than ever before. Yet longer, more frequent site visits or participation that requires extensive travel can impact a patient’s willingness ...